UK’s RoslinCT, a cell and gene therapy contract development and manufacturing organization, will be part of the Vertex Pharmaceuticals global network producing the CRISPR...
Bayer will potentially pump well over $1 billion into another major gene therapy collaboration, this time with Brisbane, California-based Mammoth BioSciences. In the pact...
An all-female team comprised of Emmanuelle Charpentier from the Max Planck Unit for the Science of Pathogens, Berlin, Germany, and Jennifer A. Doudna from the University...
08.03.2019
- The United States Patent and Trademark Office has granted Germany’s Merck a patent for its proxy-CRISPR technology. This is the Darmstadt-based pharmaceuticals and chemicals...
16.08.2018
- The Australian Patent Office has granted an application by Germany’s Merck KGaA to patent the use of paired CRISPR nickases. The Darmstadt-based group said, these “represent a...
05.06.2018
- The digital developments in the healthcare industry, combined with an aging population and enormous scientific progress, pose new challenges for pharmaceutical companies. On the...
24.04.2018
- China’s patent office has granted a patent application filed by German pharmaceuticals and chemicals producer Merck for use of the company’s CRISPR technology in a genomic...
08.11.2017
- Chinese-owned, Switzerland-based agrochemicals giant Syngenta has announced plans to acquire state-owned Chinese grains trader COFCO International’s crop seeds business for an...
